| Previous Close | 193.00 |
| Open | 193.11 |
| Bid | 192.00 x 100 |
| Ask | 197.27 x 600 |
| Day's Range | 192.65 - 194.40 |
| 52 Week Range | 161.29 - 206.63 |
| Volume | 1,109,261 |
| Avg. Volume | 1,174,970 |
| Market Cap | 44.15B |
| Beta | 1.02 |
| PE Ratio (TTM) | 56.18 |
| EPS (TTM) | 3.45 |
| Earnings Date | Nov 1, 2017 - Nov 6, 2017 |
| Dividend & Yield | 2.92 (1.51%) |
| Ex-Dividend Date | 2017-09-07 |
| 1y Target Est | 218.45 |
- Zacks•43 minutes ago
BD (BDX) Inks New Deal to Strengthen Foothold in STI Space
BD (BDX) is a leading player in providing solutions for women's health and sexually transmitted infections. Its latest development is likely to lend the company a competitive edge in the niche space.
- Zacks•23 hours ago
Becton, Dickinson Ultra-Fine Needle to Improve Diabetic Care
Becton, Dickinson and Company's (BDX) latest micro pen needle will enhance the scope of its Diabetic Care unit.
Markit•yesterdaySee what the IHS Markit Score report has to say about Becton Dickinson and Co.
Becton Dickinson and Co NYSE:BDX
